Artificial intelligence
Artificial intelligence
Artificial intelligence
Human medicines European public assessment report (EPAR): Empliciti, elotuzumab, Date of authorisation: 11/05/2016, Revision: 13, Status: Authorised
Human medicines European public assessment report (EPAR): Spikevax (previously COVID-19 Vaccine Moderna), COVID-19 mRNA vaccine, Date of authorisation: 06/01/2021, Revision: 58, Status: Authorised
Human medicines European public assessment report (EPAR): ellaOne, ulipristal acetate, Date of authorisation: 15/05/2009, Revision: 36, Status: Authorised
HMA-EMA joint Network Data Steering Group meeting - 17 July 2025
Human medicines European public assessment report (EPAR): Bortezomib Accord, bortezomib, Date of authorisation: 20/07/2015, Revision: 16, Status: Authorised
List of signals discussed at PRAC since September 2012
PRAC recommendations on safety signals
PRAC recommendations on signals adopted at the 1-4 September 2025 PRAC meeting
New product information wording: extracts from PRAC recommendations on signals adopted at the 1-4 September 2025 PRAC